| pubmed-article:20828424 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20828424 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20828424 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:20828424 | lifeskim:mentions | umls-concept:C0677582 | lld:lifeskim |
| pubmed-article:20828424 | lifeskim:mentions | umls-concept:C0445202 | lld:lifeskim |
| pubmed-article:20828424 | lifeskim:mentions | umls-concept:C0355642 | lld:lifeskim |
| pubmed-article:20828424 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20828424 | pubmed:dateCreated | 2010-10-5 | lld:pubmed |
| pubmed-article:20828424 | pubmed:abstractText | Cancer vaccines are the Holy Grail for patients and clinicians alike. The possibility that we can be vaccinated against common cancers is very appealing and the socioeconomic consequences are significant. A recent paper from Vincent Tuohy's group, published in the journal Nature Medicine, suggests a new approach for the development of a prophylactic vaccine for breast cancer. Their strategy was to induce mammary gland failure in mice by immunisation with an antibody specific to a milk protein that resulted in autoimmunity during lactation. This also showed some efficacy as a therapeutic vaccine. Can we look forward to the elimination of breast cancer? | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20828424 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20828424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20828424 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20828424 | pubmed:issn | 1465-542X | lld:pubmed |
| pubmed-article:20828424 | pubmed:author | pubmed-author:GustersonBarr... | lld:pubmed |
| pubmed-article:20828424 | pubmed:author | pubmed-author:WatsonChristi... | lld:pubmed |
| pubmed-article:20828424 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20828424 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:20828424 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20828424 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20828424 | pubmed:pagination | 310 | lld:pubmed |
| pubmed-article:20828424 | pubmed:dateRevised | 2011-10-24 | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:meshHeading | pubmed-meshheading:20828424... | lld:pubmed |
| pubmed-article:20828424 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20828424 | pubmed:articleTitle | A prophylactic vaccine for breast cancer? | lld:pubmed |
| pubmed-article:20828424 | pubmed:affiliation | Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK. cjw53@mole.bio.cam.ac.uk | lld:pubmed |
| pubmed-article:20828424 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20828424 | lld:pubmed |
